Cytolitic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer


Yazar A.

advances in modern oncology research, cilt.3, sa.5, ss.223-231, 2017 (Hakemli Dergi)